Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

secondary immune deficiency

Known as: deficiencies immune secondary 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter study.
INTRODUCTION We conducted a retrospective multicenter cohort study of patients receiving Immunoglobulin replacement therapy (IgRT… Expand
2019
2019
Octanorm [cutaquig®], a new immunoglobulin (human) subcutaneous 16.5% solution for injection (165 mg/mL) - Biochemical characterization, pathogen safety, and stability.
Octanorm (marketed as cutaquig® in Canada and US [2018] and registered in several European countries [2019]) is a new… Expand
2019
2019
Facilitated Subcutaneous Immunoglobulin (fSCIG) Administration in Secondary Immune Deficiency (SID) Due to Hematological Malignancies. Efficacy and Safety Real-World Data from a Single-Center in…
Review
2018
Review
2018
Presence of immune deficiency increases the risk of hospitalization in patients with norovirus infection.
Norovirus is an emerging pathogen causing gastroenteritis. We sought to identify factors associated with clinical outcomes in a… Expand
2017
2017
Audit of provincial IVIG Request Forms and efficacy documentation in four Ontario tertiary care centres
Retrospective audit of IVIG Request Forms in four Ontario tertiary care centres: to determine the case mix of new IVIG requests… Expand
Review
2015
Review
2015
Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities.
Vaccination has been an important healthcare measure in preventing infectious diseases. The response to vaccination is reduced in… Expand
Review
2015
Review
2015
Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.
BACKGROUND Immunocompromised patients are at increased risk for severe influenza and invasive pneumococcal diseases. Population… Expand
2015
2015
Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia
AbstractAcute lymphoblastic leukemia (ALL) is the most frequent pediatric malignancy. The chemotherapy for ALL is associated with… Expand
2013
2013
Клинико-лабораторные особенности герпесвирусной инфекции 6 типа у иммунокомпрометированных детей, наблюдающихся в детской поликлинике
In a cohort of 100 immunocompromised children aged 3 months to 12 years in continuous screening of saliva and urine with a… Expand
Review
2010
Review
2010
[Pathogenesis and clinical features of polypous rhinosinusitis].
The paper presents recommendations of the current European and Russian documents concerning pathogenesis of polypous… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE